rel-Talmapimod-hydrochloride-rel-SCIO-469-hydrochloride-生命科学试剂-MCE.pdfVIP

  • 0
  • 0
  • 约3.6千字
  • 约 2页
  • 2026-02-11 发布于上海
  • 举报

rel-Talmapimod-hydrochloride-rel-SCIO-469-hydrochloride-生命科学试剂-MCE.pdf

Hotline:400-820-3792

Inhibitors•ScreeningLibraries•Proteins

www.MedChemE

rel-Talmapimodhydrochloride

Cat.No.:HY-10406B

CASNo.:879132-01-1

Synonyms:rel-SCIO-469hydrochloride

分⼦式:C₂₇H₃₁Cl₂FN₄O₃

分⼦量:549.46

作⽤靶点:p38MAPK;TNFReceptor;InterleukinRelated;VEGFR;

Apoptosis

作⽤通路:MAPK/ERKPathway;Apoptosis;Immunology/Inflammation;

ProteinTyrosineKinase/RTK

储存⽅式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

⽣物活性rel-Talmapimod(rel-SCIO-469)hydrochloride是⼀种⼝服有效的、选择性的p38αMAPK抑制剂,其IC50为

9nM。rel-Talmapimodhydrochloride通过抑制p38αMAPK通路,抑制炎症因⼦(如TNFα、IL-1β、IL-6

和VEGF)分泌,抑制⾎管⽣成和破⾻细胞活化。rel-Talmapimodhydrochloride抑制多发性⾻髓瘤细胞⽣长并

诱导凋亡(apoptosis)。rel-Talmapimodhydrochloride可⽤于研究多种⾎液恶性肿瘤(如多发性⾻髓瘤、⾻髓

增⽣异常综合征)。

IC50Targetp38αMAPKp38βMAPKIL-6IL-1β

9nM(IC50)90nM(IC50)

客户使⽤本产品发表的科研⽂献

•Cell.2020Aug6;182(3):685-712.e19.

•SciTranslMed.2018Jul18;10(450):eaaq1093.

•CellBiolToxicol.2021Aug;37(4):515-529.

Seemorecustomervalidationsonwww.MedChemE

REFERENCES

1/2Mastero

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档